Literature DB >> 11522713

Impaired incretin response after a mixed meal is associated with insulin resistance in nondiabetic men.

E Rask1, T Olsson, S Söderberg, O Johnson, J Seckl, J J Holst, B Ahrén.   

Abstract

OBJECTIVE: To investigate whether features of the insulin resistance syndrome are associated with altered incretin responses to food intake. RESEARCH DESIGN AND METHODS: From a population-based study, 35 men were recruited, representing a wide spectrum of insulin sensitivity and body weight. Each subject underwent a hyperinsulinemic-euglycemic clamp to determine insulin sensitivity. A mixed meal was given, and plasma levels of gastric inhibitory polypeptide (GIP) and glucagon-like peptide 1 (GLP-1), as well as insulin, glucagon, and glucose were measured.
RESULTS: Insulin resistance was associated with impaired GIP and GLP-1 responses to a mixed meal. The total area under the curve (AUC) of the GIP response after the mixed meal was associated with insulin sensitivity (r = 0.54, P < 0.01). There was a significant difference between the highest and the lowest tertile of insulin sensitivity (P < 0.05). GLP-1 levels 15 min after food intake were significantly lower in the most insulin-resistant tertile compared with the most insulin-sensitive tertile. During the first hour, the AUC of GLP-1 correlated significantly with insulin sensitivity (r = 0.47, P < 0.01). Multiple linear regression analysis showed that insulin resistance, but not obesity, was an independent predictor of these decreased incretin responses.
CONCLUSIONS: In insulin resistance, the GIP and GLP-1 responses to a mixed meal are impaired and are related to the degree of insulin resistance. Decreased incretin responsiveness may be of importance for the development of impaired glucose tolerance.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11522713     DOI: 10.2337/diacare.24.9.1640

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  64 in total

Review 1.  Is glycemic variability important to assessing antidiabetes therapies?

Authors:  Boris P Kovatchev
Journal:  Curr Diab Rep       Date:  2006-11       Impact factor: 4.810

Review 2.  Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down?

Authors:  M A Nauck; I Vardarli; C F Deacon; J J Holst; J J Meier
Journal:  Diabetologia       Date:  2010-09-25       Impact factor: 10.122

3.  Functional neuroimaging of gastric distention.

Authors:  Elke Stephan; José V Pardo; Patricia L Faris; Boyd K Hartman; Suck W Kim; Emil H Ivanov; Randy S Daughters; Patricia A Costello; Robert L Goodale
Journal:  J Gastrointest Surg       Date:  2003 Sep-Oct       Impact factor: 3.452

Review 4.  Potential use of exenatide for the treatment of obesity.

Authors:  Franco Folli; Rodolfo Guardado Mendoza
Journal:  Expert Opin Investig Drugs       Date:  2011-10-24       Impact factor: 6.206

5.  GLP-1R activation for the treatment of stroke: updating and future perspectives.

Authors:  Vladimer Darsalia; David Nathanson; Thomas Nyström; Thomas Klein; Åke Sjöholm; Cesare Patrone
Journal:  Rev Endocr Metab Disord       Date:  2014-09       Impact factor: 6.514

6.  Insulin regulates glucagon-like peptide-1 secretion from the enteroendocrine L cell.

Authors:  Gareth E Lim; Guan J Huang; Nina Flora; Derek LeRoith; Christopher J Rhodes; Patricia L Brubaker
Journal:  Endocrinology       Date:  2008-09-25       Impact factor: 4.736

7.  Nutrient-driven incretin secretion into intestinal lymph is different between diabetic Goto-Kakizaki rats and Wistar rats.

Authors:  Tammy L Kindel; Qing Yang; Stephanie M Yoder; Patrick Tso
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-12-04       Impact factor: 4.052

8.  Effect of endogenous GLP-1 on insulin secretion in type 2 diabetes.

Authors:  Marzieh Salehi; Benedict Aulinger; Ronald L Prigeon; David A D'Alessio
Journal:  Diabetes       Date:  2010-03-09       Impact factor: 9.461

9.  The Incretins and Pancreatic beta-Cells: Use of Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Polypeptide to Cure Type 2 Diabetes Mellitus.

Authors:  Mi-Hyun Kim; Moon-Kyu Lee
Journal:  Korean Diabetes J       Date:  2010-02-28

Review 10.  The environment within: how gut microbiota may influence metabolism and body composition.

Authors:  A Vrieze; F Holleman; E G Zoetendal; W M de Vos; J B L Hoekstra; M Nieuwdorp
Journal:  Diabetologia       Date:  2010-01-26       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.